. Author manuscript; available in PMC: 2014 Jul 10.

Published in final edited form as: Kidney Int. 2014 Jan 8;86(1):58–66. doi: 10.1038/ki.2013.520

Table 2. Plasma oxidized amino acid concentrations.

	Fabry disease (n = 13)	Controls (n = 11)
3-nitrotyrosine	38.1 (13.6-78.9)^*	6.0 (1.7-14)
chlorotyrosine	1.6 (0.03-74.5)	1.5 (0.4-50.3)
Dityrosine	15.2 (12.6-19.5)	15 (12.9-21)
meta-tyrosine	0.2 (0.1-31.8)	15.8 (0.01-72.9)
ortho-tyrosine	16.2 (11-33.1)	18.1 (7.4-86.1)

The oxidized amino acid concentrations were assayed as described in the MATERIALS AND METHODS section. The data are expressed as μmol/mmole of total protein tyrosine and represent medians (range) of triplicate assays performed twice per sample.

p < 0.01.